Prognose

Das durchschnittliche Kursziel der Analysten beträgt +1,52€(+186,79%). Der Median liegt bei +1,52€(+186,79%).

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O'Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025.» Mehr auf globenewswire.com
Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Matt Kreps - Investor Relations Brendan O'Grady - Chief Executive Officer Ajay Patel - Chief Financial Officer. Conference Call Participants Thomas Flaten - Lake Street Naz Rahman - Maxim Group Ram Selvaraju - H.C.» Mehr auf seekingalpha.com
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
Assertio (ASRT) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.04 per share a year ago.» Mehr auf zacks.com

Im letzten Quartal hatte Assertio Holdings einen Umsatz von 24,48 Mio€ und ein Nettoeinkommen von −12,06 Mio€